M
MIRA Pharmaceuticals, Inc. (MIRA)
NCM – Real Time Price. Currency in USD
1.01
+0.10 (11.27%)
At close: Jun 26, 2026, 4:00 PM EDT
1.01
0.00 (0.00%)
After-hours: Jun 26, 2026, 7:45 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NCM – Real Time Price. Currency in USD
1.01
+0.10 (11.27%)
At close: Jun 26, 2026, 4:00 PM EDT
1.01
0.00 (0.00%)
After-hours: Jun 26, 2026, 7:45 PM EDT
Revenue breakdown data has not been calculated yet.
No Data
There are no news for this stock.
Cash reserves $4.8M barely cover the upcoming debt maturities $0.0
Total current assets $9.4M exceed Total current liabilities $114.8K, highlighting excellent liquidity
Debt-to-equity ratio (0.0) is near the industry average, reflecting balanced leverage
Interest expense exists but EBIT data is unavailable, indicating potential profitability concerns
Negative free cash flow -$1.2M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 82.16 | 1.97 | 10 | |
| Quick ratio | 82.16 | 1.37 | 10 | |
| Debt to Equity | 0.00 | -7.73 | 10 | |
| Debt to Assets | 0.00 | 0.29 | 10 | |
| Interest coverage | N/A | 36.83 | 1.0 | |
| Weighted average score | 8.2 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | N/A | N/A | N/A | N/A | N/A |
| Operating Income | -7M | -9M | -8M | -10M | -10M |
| Net Income | -7M | -12M | -8M | -32M | -31M |
| EBITDA | -7M | -9M | -8M | -10M | -10M |
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Gross margin % | N/A | 67.05 | 1.0 | |
| Operating margin % | N/A | 0.14 | 1.0 | |
| Net margin % | N/A | 9.34 | 1.0 | |
| EBITDA margin % | N/A | 19.90 | 1.0 | |
| Cash flow margin % | N/A | 21.79 | 1.0 | |
| Weighted average score | 1.0 | |||
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | N/A | 1.0 |
| Next quarter | N/A | N/A | 1.0 |
| Current year | N/A | N/A | 1.0 |
| Next year | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 999 | 80.78 | N/A | -5.83 | 5.5 |
| Y/Y | 999 | 35.52 | N/A | 26.3 | 7.8 |
| 3y average | 999 | -114.25 | N/A | 5.66 | 4.3 |
| 5y average | 999 | -733.63 | N/A | -442.86 | 3.3 |
| Weighted average score | 5.2 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |